Jakavi 15mg (Ruxolitinib Tablet) 15mg

Jakavi 15mg (Ruxolitinib) is an oral tablet used for certain blood disorders. It helps manage symptoms by targeting specific pathways in the body. Store at room temperature and keep out of reach of children. Not all patients qualify for this treatment.

Strength

15mg

Pack Size

56s

Storage

Ambient

Manufacturer / TM Owner

Novartis Pharma Stein AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Jakavi 15mg is primarily used to treat myelofibrosis and polycythemia vera, conditions affecting the bone marrow. It may also be prescribed for graft-versus-host disease in some cases. Patients often ask, 'what is Jakavi 15mg used for' to understand its role in managing chronic conditions. Always consult a healthcare provider for suitability.

Side Effects

Many patients report reduced symptoms such as fatigue and enlarged spleen after starting Jakavi 15mg. Some experience changes in blood cell counts, which are monitored during treatment. Effects vary by individual, and regular check-ups help track progress. Side effects like dizziness or nausea may occur but are not universal.

Precautions & Warnings

Jakavi 15mg should be handled with care, especially around children and pets. Avoid crushing or splitting tablets unless directed. Inform your doctor about any infections or liver issues before starting. Keep the medication in its original packaging to protect it from moisture.

Avoid Interactions

Jakavi 15mg may interact with strong CYP3A4 inhibitors or inducers, affecting its levels in the body. Grapefruit products can also alter how the drug works. Always disclose all medications, including over-the-counter and herbal products, to your healthcare provider. Alcohol use should be discussed with a doctor.

Frequently Asked Questions

Jakavi 15mg is used to treat myelofibrosis and polycythemia vera, conditions that affect the bone marrow.

Store Jakavi 15mg at room temperature, away from moisture and direct sunlight.

Some medications may interact with Jakavi 15mg; consult your doctor before combining treatments.

Common effects may include dizziness, nausea, or changes in blood cell counts.

The safety of Jakavi 15mg during pregnancy has not been established; discuss risks with your healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.